Under the concept of innovative drugs, SDKX fell by more than 9%
Under the decline of innovative drug concepts, SDKX fell more than 9%, while HWPC, ANKE BIO, Froniter Biotechnologies and other stocks fell over 5%
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments